Vertex Pharmaceuticals, Inc.’s recently made public that its Director SACHS BRUCE I acquired Company’s shares for reported $2.69 million on Aug 01 ’24. In the deal valued at $508.00 per share,5,295 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, SACHS BRUCE I sold 5,295 shares, generating $2,689,860 in total proceeds. Upon selling the shares at $508.00, the Director now owns 40,000 shares.
Before that, Kewalramani Reshma bought 15,202 shares. Vertex Pharmaceuticals, Inc. shares valued at $7,677,010 were divested by the Officer at a price of $505.00 per share.
Barclays downgraded its Vertex Pharmaceuticals, Inc. [VRTX] rating to an Equal weight from a an Overweight in a research note published on August 05, 2024; the price target was increased to $509 from $472. A number of analysts have revised their coverage, including Redburn Atlantic’s analysts, who began to cover the stock in late June with a ‘”a Buy”‘ rating. Evercore ISI also remained covering VRTX and has increased its forecast on April 11, 2024 with a “an Outperform” recommendation from previously “an In-line” rating. Wolfe Research started covering the stock on February 15, 2024. It rated VRTX as “an Outperform”.
Price Performance Review of VRTX
On Monday, Vertex Pharmaceuticals, Inc. [NASDAQ:VRTX] saw its stock fall -3.55% to $476.91. Over the last five days, the stock has lost -4.26%. Vertex Pharmaceuticals, Inc. shares have risen nearly 17.21% since the year began. Nevertheless, the stocks have risen 37.15% over the past one year. While a 52-week high of $510.64 was reached on 08/01/24, a 52-week low of $340.20 was recorded on 04/18/24. SMA at 50 days reached $479.05, while 200 days put it at $421.46. A total of 2.22 million shares were traded, compared to the trading of 1.53 million shares in the previous session.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 465.59, which if violated will result in even more drops to 454.27. On the upside, there is a resistance level at 486.02. A further resistance level may holdings at 495.13. The Relative Strength Index (RSI) on the 14-day chart is 42.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.92, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.37%. Stochastics%K at 54.20% indicates the stock is a holding.
